pharmaphorum

MARCH 30, 2021

She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. “When we come together like this, innovation can happen a lot faster.”. About the author.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

Express Pharma

JUNE 21, 2024

Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. ILR(2009)Supp.(2)Delhi Union of India4 (2013 (6) SCC 1), the Division Bench of Delhi High Court in the case of F. Hoffmann-LA Roche and Ors. Vs. Cipla5.

Generic Medicine 102

Generic Medicine Vaccines Immunity Immunization 102

European Pharmaceutical Review

FEBRUARY 23, 2023

Replacing the rabbit pyrogen test The texts covering topics such as vaccines for human use, blood products, antibiotics, radiopharmaceuticals and containers, have now been revised to replace the RPT with an in vitro alternative, the monocyte activation test (MAT) or another animal welfare-compatible approach. General chapter 2.6.30.

Vaccines 98

Vaccines 98

Express Pharma

JUNE 12, 2024

Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. ILR(2009)Supp. (2)Delhi Union of India (4) (2013 (6) SCC 1), the Division Bench of Delhi High Court in the case of F. Hoffmann-LA Roche and Ors. Vs. Cipla (5).

Generic Medicine 105

Generic Medicine Vaccines Immunity Immunization 105

PharmaShots

FEBRUARY 21, 2023

Market Cap: $8.57M Founded Year: 2009 Total Employees: ~40 Headquarters: Oslo, Norway Stock Exchange: OSE Nordic Nanovector is a biotech company committed to developing and commercializing antibody-radionuclide conjugates to address significant unmet medical needs. In Aug’21, the US FDA cleared QSam’s IND application for CycloSam.

Dosage 56

Dosage Labelling Immunity Immunization 56

FDA Law Blog: Biosimilars

FEBRUARY 4, 2025

In the eleven years from 2009 to the end of 2019, FDA awarded 11 tropical disease PRVs for the development of therapies for diseases such as malaria, tuberculosis, dengue, and river blindness. See Table 1. While lapse of this program may raise concerns about the end of the Tropical Disease PRV, such a result is highly unlikely.

Vaccines 52

Vaccines 52

pharmaphorum

OCTOBER 24, 2022

Exemptions include exceptional central procurements, centrally procured vaccines, small company sales, and low-value sales (when the NHS list price is less than £2). For company bottom lines, it matters just what sales this rebate applies to, since the deal also sets out when the rebates don’t apply.

Vaccines 75

Vaccines 75

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 Its oncology treatment Arimidex lost exclusivity in the US in 2009, accounting for a sales decrease of 86%, as published in the 2010 annual report.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

pharmaphorum

MARCH 15, 2021

There are of course many unknowns when we consider how treatment for COVID-19 will evolve in the future, and how testing, therapeutics and vaccines will interact as we attempt to end the pandemic. Eran Eden has been the CEO of MeMed since its inception in 2009, leading it from an idea to a rapidly growing company. About the author.

Immunity 71

Immunity Immunization Vaccines 71

pharmaphorum

JANUARY 13, 2021

Dr Kirsty Wydenbach is an expert medical assessor and the deputy unit manager in the Clinical Trials Unit at MHRA , having joined in 2009. More recently Kirsty has overseen the clinical trial work for COVID-19 and provided regulatory expertise on vaccines both within MHRA but also as part of the government Vaccine Taskforce.

Medical Schools 52

Medical Schools Hospitals Vaccines 52

pharmaphorum

JANUARY 13, 2021

Dr Kirsty Wydenbach is an expert medical assessor and the deputy unit manager in the Clinical Trials Unit at MHRA , having joined in 2009. More recently Kirsty has overseen the clinical trial work for COVID-19 and provided regulatory expertise on vaccines both within MHRA but also as part of the government Vaccine Taskforce.

Medical Schools 52

Medical Schools Hospitals Vaccines 52

PharmaShots

APRIL 13, 2023

2009 was a challenging year for multinational companies due to the recession and currency fluctuations Johnson & Johnson's performance graph declined by 2.9% Despite a challenging year, Johnson & Johnson acquired Cougar and Elan Pfizer's 2009 performance was significant as compared to 2008 with the addition of Wyeth.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Express Pharma

MAY 10, 2024

With its dominance in generic medicine production, resilience amidst the COVID-19 pandemic, leadership in vaccine manufacturing, and collaborative efforts in research and development, our country plays a pivotal role in delivering quality-certified medications at significantly lower costs.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

APRIL 16, 2024

With its dominance in generic medicine production, resilience amidst the COVID-19 pandemic, leadership in vaccine manufacturing, and collaborative efforts in research and development, our country plays a pivotal role in delivering quality-certified medications at significantly lower costs.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MARCH 22, 2023

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunity 97

Immunity Immunization Vaccines Communication 97

PharmaShots

FEBRUARY 20, 2023

However, upstream production in plants must also comply with additional laws relating to environmental release if grown outdoors (Directive 2001/ 18/EC, and 1829/2003/EC if the crop can be used as food/ feed) and Directive 2009/41EC if grown in constraint. However, these VLPs do not contain genetic material, making them non-infectious.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

pharmaphorum

JUNE 6, 2025

Website and content copyright © 2009- 2025 , pharmaphorum media limited or its licensors; all rights reserved. Website and content copyright © 2009- 2025 , pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company The rights of trademark owners are acknowledged.

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

Pharmacy Times

JULY 18, 2022

Influenza viruses typically circulate in the Northern Hemisphere during the winter and spring, but they occasionally can circulate more during the summer months, as did the 2009 H1N1 pandemic strain.

Vaccines 26

Vaccines 26

pharmaphorum

DECEMBER 2, 2020

Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers in the world.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

pharmaphorum

FEBRUARY 26, 2021

The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents.

Vaccines 126

Vaccines Biosimilars Labelling Communication 126

pharmaphorum

JANUARY 5, 2021

Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at. These changes are likely to reduce only slowly in the Vaccine+ environment, and will not be entirely reversed.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

FEBRUARY 16, 2021

President Joe Biden asked Slaoui to step down as chief scientific adviser to the US COVID-19 vaccine initiative after the White House administration changed late last month and the former GlaxoSmithKline research chief wasted no time in finding a new project.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

Pharmaceutical Technology

AUGUST 26, 2008

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.” The blood pressure results are expected in the first half of 2009.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development Vaccines 40

Putting Patients First Blog

SEPTEMBER 9, 2024

Preventive Services The expansion of preventive services, including hepatitis B vaccinations and colorectal cancer screenings, is a positive development for public health. 30 Hepatitis B vaccinations and colorectal cancer screenings are vital components of a comprehensive preventive care strategy. 6 Singh, G. and Siapush, M.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

STAT

NOVEMBER 29, 2024

The vaccine, approved by the WHO in 2009 , eliminates the human papilloma virus, which is the leading cause of cervical cancer. The vaccine is a scientific triumph — a silver bullet that could, single-handedly, virtually end one of the most common and deadly forms of cancer.

Vaccines 336

Vaccines 336

pharmaphorum

FEBRUARY 5, 2021

One high-profile project has been the use of real-world data during the approval of COVID-19 vaccines, something that she discussed in an emailed interview with pharmaphorum earlier in the pandemic. Hahn had to fight off pressure from the Trump administration to approve Pfizer’s vaccine early.

Vaccines 119

Vaccines Biosimilars Labelling 119

The Thyroid Pharmacist

NOVEMBER 8, 2024

After being diagnosed with Hashimoto’s in 2009, I spent a lot of time, money, and resources on trying to figure out my root cause. A new test is being developed for MAP detection in support of a vaccine for Crohn’s disease; it has been in clinical trials, and looks very promising. In one study, genetically susceptible mice with E.

Immunity 80

Immunity Immunization Diabetes Adverse Reactions 80